Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Olga Bobiļeva
Observed names:
Bobileva, Olga,
Bobiļeva, O.,
O. Bobileva,
O. Bobiļeva,
Olga Bobileva
Institutions:
Czech Academy of Sciences,
Latvijas Organiskās Sintēzes Institūts,
Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry
Observed institutions:
Czech Academy of Sciences,
Latvijas Organiskās Sintēzes Institūts,
Institute of Organic Synthesis,
Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry
ORCID:
0000-0001-9600-1603
Observed ORCID:
0000-0001-9600-1603
OpenAlex ID:
A5028986804
Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate
2021
·
Olga Bobiļeva
, Raitis Bobrovs
, et al.
·
ACS Medicinal Chemistry Letters
·
73
PDF
Small-Molecule Inhibitors of the m7G-RNA Writer METTL1
2023
·
Francesco Nai
, Maria Paula Flores Espinoza
, et al.
·
ACS Bio & Med Chem Au
·
37
PDF
Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria
2024
·
Douglas L. Huseby
, Sha Cao
, et al.
·
Proceedings of the National Academy of Sciences
·
30
3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors
2023
·
Olga Bobileva
, Raitis Bobrovs
, et al.
·
Molecules
·
29
PDF
Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists
2014
·
Olga Bobileva
, Rasma Bokaldere
, et al.
·
Bioorganic & Medicinal Chemistry
·
9
Targeting the METTL1/m⁷G axis as a therapeutic strategy in myeloid leukemia
2026
·
Ren, Lili
, Zhang, Honghai
, et al.
·
Zurich Open Repository and Archive (University of Zurich)
·
6
Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors
2024
·
Gints Kalnins
, Laura Rudusa
, et al.
·
ChemMedChem
·
6
PDF
Synthesis and evaluation of (E)-2-(5-phenylpent-2-en-4-ynamido)cyclohex-1-ene-1-carboxylate derivatives as HCA2 receptor agonists
2017
·
Olga Bobileva
, Martins Ikaunieks
, et al.
·
Bioorganic & Medicinal Chemistry
·
5
Synthesis of 2-substituted oxazoloquinazolinones
2018
·
Olga Bobiļeva
, Einārs Loža
·
Chemistry of Heterocyclic Compounds
·
3
Design, synthesis, and in vitro biological evaluation of meta-sulfonamidobenzamide-based antibacterial LpxH inhibitors
2024
·
Andrea Benediktsdottir
, Sanjeewani Sooriyaarachchi
, et al.
·
European Journal of Medicinal Chemistry
·
2
PDF
Synthesis of 2-quinolinecarboxamide derivatives as potential HDAC inhibitors
2011
·
O. Habarova
, O. Bobiļeva
, et al.
·
Chemistry of Heterocyclic Compounds
·
2
Adenosine 5′-Carboxamide-Based Inhibitors of METTL1
2026
·
Olga Bobileva
, Francesco Nai
, et al.
·
ACS Medicinal Chemistry Letters
·
1
PDF
Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia
2025
·
Lili Ren
, Honghai Zhang
, et al.
·
Blood
·
1
HCA2受容体作動薬としての(E)‐2-(5-フェニルペンテ-2-en-4-ynamido)cyclohex-1-エン-1-カルボキシラート誘導体の合成と評価【Powered by NICT】
2017
·
Olga Bobiļeva
, Martins Ikaunieks
, et al.
·
Bioorganic & Medicinal Chemistry
·
1
Characterization of the N7 RNA cap methyltransferase from Trichomonas vaginalis and inhibitor discovery
2026
·
Jakub Benysek
, Dominika Chalupska
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Crystal structure of human METTL1 in complex with OBV617 (compound B19)
2026
·
F. Nai
, O. Bobileva
, et al.
·
Worldwide Protein Data Bank
Hidroksikarbonskābju receptoru sintētisko ligandu pētījumi
2019
·
Olga Bobiļeva
CCDC 1840303: Experimental Crystal Structure Determination
2019
·
Bobiļeva, O.
, Loža, E.
·
The Cambridge Structural Database
3’-Aril- un heterilaizvietotās 2-akrilamidocikloheks-1-ēnkarbonskābes kā hidroksikarbonskābju receptoru saimes (hca2) jauna ligandu grupa
2015
·
Einārs Loža
, Olga Bobiļeva
, et al.
·
publication.editionName
ChemInform Abstract: Synthesis of 2‐Quinolinecarboxamide Derivatives as Potential HDAC Inhibitors.
2012
·
O. Habarova
, O. Bobileva
, et al.
·
ChemInform
Show more works
View as search
Works count:
21
Citation count:
205
H-index:
6
I10-index:
4
Year
Topic
Type